EE03778B1 - Vähivaktsiin ja selle valmistamismeetod - Google Patents
Vähivaktsiin ja selle valmistamismeetodInfo
- Publication number
- EE03778B1 EE03778B1 EE9800161A EE9800161A EE03778B1 EE 03778 B1 EE03778 B1 EE 03778B1 EE 9800161 A EE9800161 A EE 9800161A EE 9800161 A EE9800161 A EE 9800161A EE 03778 B1 EE03778 B1 EE 03778B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- cancer vaccine
- vaccine
- cancer
- Prior art date
Links
- 238000009566 cancer vaccine Methods 0.000 title 1
- 229940022399 cancer vaccine Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19543649A DE19543649C2 (de) | 1995-11-23 | 1995-11-23 | Tumorvakzine und Verfahren zu ihrer Herstellung |
DE19607044A DE19607044A1 (de) | 1996-02-24 | 1996-02-24 | Tumorvakzine und Verfahren zu ihrer Herstellung |
PCT/EP1996/005126 WO1997019169A1 (de) | 1995-11-23 | 1996-11-21 | Tumorvakzine und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9800161A EE9800161A (et) | 1998-12-15 |
EE03778B1 true EE03778B1 (et) | 2002-06-17 |
Family
ID=26020603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9800161A EE03778B1 (et) | 1995-11-23 | 1996-11-21 | Vähivaktsiin ja selle valmistamismeetod |
Country Status (24)
Country | Link |
---|---|
US (1) | US20020085997A1 (et) |
EP (1) | EP0866851A1 (et) |
JP (1) | JP2000502052A (et) |
KR (1) | KR19990067653A (et) |
CN (1) | CN1202931A (et) |
AR (1) | AR004341A1 (et) |
AU (1) | AU720131B2 (et) |
BG (1) | BG62999B1 (et) |
BR (1) | BR9611466A (et) |
CA (1) | CA2238176A1 (et) |
CO (1) | CO4520254A1 (et) |
CZ (1) | CZ158998A3 (et) |
EE (1) | EE03778B1 (et) |
HU (1) | HUP0000318A3 (et) |
NO (1) | NO982329D0 (et) |
NZ (1) | NZ322910A (et) |
PL (1) | PL188537B1 (et) |
RO (1) | RO115275B1 (et) |
RU (1) | RU2206329C2 (et) |
SK (1) | SK66998A3 (et) |
TR (1) | TR199800912T2 (et) |
TW (1) | TW514530B (et) |
UY (2) | UY24367A1 (et) |
WO (1) | WO1997019169A1 (et) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4600681A1 (es) † | 1996-02-24 | 1998-05-08 | Boehringer Ingelheim Pharma | Composicion farmaceutica para la modulacion inmunitaria |
EP1012240B1 (en) * | 1997-01-31 | 2008-03-19 | Edward P. Cohen | Cancer immunotherapy with semi-allogeneic cells |
EP0904786B1 (en) * | 1997-08-22 | 2004-12-15 | Science Park Raf S.p.A. | Tumor vaccination by use of autologous or HLA-related antigen presenting cell (APC) transduced with a tumour antigen and a foreign antigen capable of causing an immune reaction |
US7014848B1 (en) | 1998-03-20 | 2006-03-21 | Genzyme Corporation | Enhanced anti-tumor immunity |
AU3102799A (en) * | 1998-03-20 | 1999-10-11 | Genzyme Corporation | Enhanced anti-tumor immunity |
FR2807661A1 (fr) * | 2000-04-14 | 2001-10-19 | Univ Nantes | Agent et procede pour la simulation de lymphocytes t specifiques et lymphocytes t obtenus |
CA2476995A1 (en) * | 2001-09-18 | 2003-03-27 | Kyogo Itoh | Method of detecting cellular immunity and application thereof to drugs |
GB0209896D0 (en) | 2002-04-30 | 2002-06-05 | Molmed Spa | Conjugate |
CN1315536C (zh) * | 2002-09-13 | 2007-05-16 | 李进 | 肿瘤抗原疫苗及其制备方法和疫苗组合物 |
GB0224442D0 (en) | 2002-10-21 | 2002-11-27 | Molmed Spa | A delivery system |
DK1667711T3 (da) * | 2003-08-25 | 2010-11-22 | Univax Llc | Forebyggende cancervaccine baseret på BORIS (Brother of Regulator of Imprinted Sites)-molekyle |
US7674456B2 (en) * | 2004-06-14 | 2010-03-09 | Charles Wiseman | Breast cancer cell lines and uses thereof |
CA2603191A1 (en) * | 2005-03-29 | 2006-10-05 | The Board Of Trustees Of The University Of Illinois | Cancer vaccines and therapeutic methods |
EP1806359B1 (en) * | 2005-09-05 | 2010-03-17 | Immatics Biotechnologies GmbH | Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
US8765148B2 (en) | 2010-02-19 | 2014-07-01 | Valneva Austria Gmbh | 1C31 nanoparticles |
AU2013289939B2 (en) * | 2012-07-12 | 2018-08-09 | Persimmune, Inc. | Personalized cancer vaccines and adoptive immune cell therapies |
JP2020518648A (ja) | 2017-05-08 | 2020-06-25 | グリットストーン オンコロジー インコーポレイテッド | アルファウイルス新生抗原ベクター |
WO2020243719A1 (en) | 2019-05-30 | 2020-12-03 | Gritstone Oncology, Inc. | Modified adenoviruses |
AU2021320896A1 (en) | 2020-08-06 | 2023-03-23 | Gritstone Bio, Inc. | Multiepitope vaccine cassettes |
CN117222418A (zh) * | 2021-03-12 | 2023-12-12 | T-Cure生物科学公司 | 增强肿瘤中的hla单倍型表达多样性以扩大肿瘤细胞对tcr-t疗法的敏感性的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235525B1 (en) * | 1991-05-23 | 2001-05-22 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
EP0569678A3 (en) * | 1992-03-13 | 1994-10-26 | Yeda Res & Dev | Double transfectants of MHC genes as cellular vaccines for immunoprevention of tumor metastasis. |
-
1996
- 1996-11-19 UY UY24367A patent/UY24367A1/es not_active IP Right Cessation
- 1996-11-21 JP JP9519395A patent/JP2000502052A/ja not_active Abandoned
- 1996-11-21 US US09/077,214 patent/US20020085997A1/en not_active Abandoned
- 1996-11-21 CN CN96198493A patent/CN1202931A/zh active Pending
- 1996-11-21 RU RU98111622/14A patent/RU2206329C2/ru not_active IP Right Cessation
- 1996-11-21 PL PL96326756A patent/PL188537B1/pl not_active IP Right Cessation
- 1996-11-21 SK SK669-98A patent/SK66998A3/sk unknown
- 1996-11-21 CZ CZ981589A patent/CZ158998A3/cs unknown
- 1996-11-21 EP EP96939870A patent/EP0866851A1/de not_active Withdrawn
- 1996-11-21 BR BR9611466A patent/BR9611466A/pt not_active Application Discontinuation
- 1996-11-21 EE EE9800161A patent/EE03778B1/et not_active IP Right Cessation
- 1996-11-21 RO RO98-00985A patent/RO115275B1/ro unknown
- 1996-11-21 KR KR1019980703681A patent/KR19990067653A/ko not_active Application Discontinuation
- 1996-11-21 TR TR1998/00912T patent/TR199800912T2/xx unknown
- 1996-11-21 CA CA002238176A patent/CA2238176A1/en not_active Abandoned
- 1996-11-21 WO PCT/EP1996/005126 patent/WO1997019169A1/de not_active Application Discontinuation
- 1996-11-21 HU HU0000318A patent/HUP0000318A3/hu unknown
- 1996-11-21 NZ NZ322910A patent/NZ322910A/xx unknown
- 1996-11-21 AU AU76947/96A patent/AU720131B2/en not_active Ceased
- 1996-11-22 AR ARP960105291A patent/AR004341A1/es not_active Application Discontinuation
- 1996-11-22 CO CO96061701A patent/CO4520254A1/es unknown
- 1996-11-23 TW TW085114455A patent/TW514530B/zh not_active IP Right Cessation
-
1997
- 1997-01-03 UY UY24430A patent/UY24430A1/es not_active IP Right Cessation
-
1998
- 1998-05-08 BG BG102439A patent/BG62999B1/bg unknown
- 1998-05-22 NO NO982329A patent/NO982329D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
JP2000502052A (ja) | 2000-02-22 |
RO115275B1 (ro) | 1999-12-30 |
EP0866851A1 (de) | 1998-09-30 |
AR004341A1 (es) | 1998-11-04 |
TR199800912T2 (xx) | 1998-08-21 |
HUP0000318A3 (en) | 2002-02-28 |
RU2206329C2 (ru) | 2003-06-20 |
WO1997019169A1 (de) | 1997-05-29 |
PL188537B1 (pl) | 2005-02-28 |
AU720131B2 (en) | 2000-05-25 |
SK66998A3 (en) | 1998-12-02 |
CA2238176A1 (en) | 1997-05-29 |
CZ158998A3 (cs) | 1999-06-16 |
UY24430A1 (es) | 1997-07-01 |
EE9800161A (et) | 1998-12-15 |
US20020085997A1 (en) | 2002-07-04 |
KR19990067653A (ko) | 1999-08-25 |
BG62999B1 (bg) | 2001-01-31 |
AU7694796A (en) | 1997-06-11 |
BR9611466A (pt) | 1999-05-18 |
PL326756A1 (en) | 1998-10-26 |
HUP0000318A2 (hu) | 2000-06-28 |
NZ322910A (en) | 2000-05-26 |
NO982329D0 (no) | 1998-05-22 |
CN1202931A (zh) | 1998-12-23 |
BG102439A (en) | 1999-01-29 |
TW514530B (en) | 2002-12-21 |
CO4520254A1 (es) | 1997-10-15 |
UY24367A1 (es) | 2000-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03778B1 (et) | Vähivaktsiin ja selle valmistamismeetod | |
FI951340A0 (fi) | SOI-substraatti ja menetelmä sen valmistamiseksi | |
EE9900014A (et) | Erütromütsiinid ja nende valmistamise protsess | |
EE03409B1 (et) | Kõrge efektiivsusega segusti ja selle valmistamise meetod | |
FI941137A (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
FI973378A (fi) | Laite ja menetelmä | |
EE03482B1 (et) | Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine | |
EE9700318A (et) | Optiline seade ja meetod | |
DE69625368D1 (de) | Schweisshemmende deodorierende präparaten | |
DK0729956T3 (da) | Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder | |
FI98529B (fi) | Menetelmä ja laitteisto keveiden olefiinien valmistamiseksi | |
KR960007649A (ko) | 공중합 폴리아미드 및 그의 제조방법 | |
NO974169D0 (no) | Fremgangsmåte for tetra-azacykloalkan-fremstilling | |
BR9602983A (pt) | Gel e processo para sua preparação | |
FI952229A (fi) | Kuumuutta kestävä hiusvalmiste ja menetelmä sen käyttämiseksi | |
EE03738B1 (et) | Hambaimplantaatsüsteem ja meetod selle valmistamiseks | |
DE69629457D1 (de) | Impfstoff in gelform | |
FI964310A (fi) | Imidatsolijohdannainen ja menetelmä sen valmistamiseksi | |
DE69630611D1 (de) | Antigenische präparationen | |
DK0826679T3 (da) | Naphthylforbindelser og -præparater | |
EE03387B1 (et) | Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks | |
BR9708979A (pt) | Complexo imunogénico utilização do mesmo vacina processo para a preparação de um complexo imunogenico e utilização de uma proteína | |
FI940403A (fi) | Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi | |
FI963330A (fi) | Menetelmä ja järjestelmä ainesseoksesta tapahtuvaa näytteenottoa varten | |
NO960766D0 (no) | Nytt protein og fremgangsmåte for fremstilling av dette |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20041121 |